Neuro-Oncology Reviews
Volume
28 Number 22
10 August 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 22, 10 August
Bazer D, Ayanlaja AA, Schreck KC.
Practical
management of BRAF inhibitors in glioma: toxicity and resistance.
CNS
Oncol. 2026 Aug 3;15(1):2711620. doi:
10.1080/20450907.2026.2711620. PMID:
42544547. ˍ
Jiang E, Dai Z, Zhao H, Zhou H, Liu M.
Multimodal
cell death-associated inflammatory niches recruit but spatially
constrain GZMB+
cytotoxic T lymphocytes in glioblastoma.
Clin
Immunol. 2026 Aug 3:110757. doi:
10.1016/j.clim.2026.110757. PMID:
42546950˰ ˍ
Tiwari A, Pawlowski KD, Balyasnikova IV.
Improving
T-cell engager efficacy in glioblastoma with multi-antigen
targeting and novel delivery approaches.
Acta
Neuropathol. 2026 Aug 3;152(1):15. doi:
10.1007/s00401-026-03063-w. PMID:
42545507. ˍ
Yan Y, Zhang B, Chen S, Sun Y, Huang J, Li G.
Rethinking
glioma-associated senescence: Drivers of heterogeneity and
therapeutic resistance.
Biochim
Biophys Acta Rev Cancer. 2026 Aug 3;1881(5):189673.
doi:
10.1016/j.bbcan.2026.189673. PMID:
42546852˰ ˍ
AlRamadneh TN, S RJ, Nayak PP, Nanda A, Hasnaawei SA, Bhatt A,
Chauhan AS, Singla S, Nourizadeh M.
Microbiota-Neuroinflammation
Crosstalk in Primary Brain Tumors: Focus on Glioblastoma.
Brain
Behav. 2026 Aug 5;16(8):e71648. doi:
10.1002/brb3.71648. PMID:
42553012. ˍ
Massimino M, Stella S, Di Grazia G, Tomarchio C, Vitale SR,
Martorana F, Pellegriti G, Magro G, Broggi G, Salvatorelli L,
Caltabiano R, Manzella L, Vigneri P.
Revisiting
Diffuse Gliomas in the Era of Precision Medicine: Molecular
Insights and Therapeutic Implications.
Crit
Rev Oncol Hematol. 2026 Aug 5:105511. doi:
10.1016/j.critrevonc.2026.105511. PMID:
42556593. ˍ
Matar H, Alrabadi B, Abu Ata A, Bahdar Z, Zagiczek M.
Depatuxizumab mafodotin in
glioblastoma: A systematic review of efficacy, safety,
pharmacokinetics and biomarker stratification. J
Oncol Pharm Pract. 2026 Aug 5:10781552261470027. doi:
10.1177/10781552261470027. PMID:
42554799˰ ˍ
Mendonca NC, Liu L, Chen KS, Shah K.
Extracellular
vesicles: Navigating new frontiers in glioblastoma therapy.
Neurotherapeutics.
2026 Aug 6;23(6):e01036. doi:
10.1016/j.neurot.2026.e01036. PMID:
42561868. ˍ
Carrion YL, Bhasin J, Anne S, Sawhney A, Ha CJ, Sharaf I, Santana
J, Titkov K, Jean M, Thibault D, Pando A, Novakovic N, Parikh NS,
Vojnic M, Sherman JH.
Locoregional and
systemic adoptive cellular therapies for pediatric brain tumors: a
systematic review of CAR-T, TCR-engineered T cells, and NK cell
strategies.
Neurosurg
Rev. 2026 Aug 7;49(1):519. doi:
10.1007/s10143-026-04437-0. PMID:
42566099. ˍ
Li W, Chen JM, Ma YC.
Pathway
dysregulation and therapeutic resistance in glioblastoma:
molecular mechanisms and emerging therapeutic targets.
Future
Sci OA. 2026 Aug 10;12(1):2715646. doi:
10.1080/20565623.2026.2715646. PMID:
42573440. ˍ
Kaushal A, Waindeskar V, Padala SRAN, Kumar S, Jain I, Agrawal A.
Awake craniotomy for brain tumors
during pregnancy: An updated scoping review.
J
Anaesthesiol Clin Pharmacol. 2026 May 19;42(3):350-357.
doi:
10.4103/joacp.joacp_734_25. PMID:
42541244. ˍ
Ramireddy VVS, Shaikh RG, Pednekar AR, Tripathi D, Munde CT, Wagh
K.
A Systematic Literature Review of
Emerging Advances in Neurological Disorders: Diagnostic
Innovations, Therapeutic Strategies, and Future Directions.
Cureus.
2026 Jul 7;18(7):e112202. doi:
10.7759/cureus.112202. PMID:
42565151. ˍ
Pailas A, Vales de Almeida AC, Torres-Fernández M, Chalmers A,
Mittelbronn M, Van Dyck E.
Targeting
replication stress in glioblastoma: From genotoxic treatment and
inhibitors of the DNA damage response to immunotherapy.
Neurooncol
Adv. 2026 Jul 9;8(1):vdag177. doi:
10.1093/noajnl/vdag177. PMID:
42549406. ˍ
Bryukhovetskiy I, Pak O, Polevshchikov A.
Glioblastoma
stem cells as carriers of tumour memory: a strategy for
personalised immunotherapy using tumour-infiltrating lymphocytes.
Front
Immunol. 2026 Jul 22;17:1880908. doi:
10.3389/fimmu.2026.1880908. PMID:
42558850. ˍ
Vershinina O, Turubanova V, Franceschi C, Ivanchenko M.
Towards
a personalized perspective on gliomas: an
epigenetic-immuno-inflammatory aging framework.
Front
Immunol. 2026 Jul 22;17:1898095. doi:
10.3389/fimmu.2026.1898095. PMID:
42558471. ˍ
Mohammed Aleid A, Abdullah Houlbah I, Yahya Abutaleb M, Mohammed
Hakami M, Ali M Alshahrani F, Khalid Aldawsari S, Ahmed Salem
Algethmi R, Abdulrahman Ismail A, Fadhel Almalki S.
Dendritic
Cell Vaccines for Glioblastoma: A Systematic Review and
Meta-Analysis Comparing New-Onset and Recurrent Cases.
Anticancer
Agents Med Chem. 2026 Jul 27. doi:
10.2174/0118715206406017251124090916. PMID:
42565415. ˍ
Onyekweli SO, Omoruyi GO, Akintayo CO, Olaniyi SK.
Engineering
CAR-T cells for solid tumors: Overcoming the microenvironment
through integrated design and clinical translation.
Oncoscience.
2026 Jul 29;13:227-249. doi:
10.18632/oncoscience.666. PMID:
42540518. ˍ